| ClinicalTrials.gov Identifier: |
NCT01555164 |
| Brief Title: |
A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone |
|
|
First Submitted : |
March 13, 2012 |
|
First Submitted that Met QC Criteria : |
March 13, 2012 |
|
First Posted : |
March 15, 2012
(Estimate)
|
|
|
Results First Submitted : |
September 17, 2014 |
|
Results First Submitted that Met QC Criteria : |
September 17, 2014 |
|
Results First Posted : |
September 23, 2014
(Estimate)
|
|
|
Certification/Extension First Submitted : |
January 17, 2014 |
|
Certification/Extension First Submitted that Met QC Criteria : |
January 17, 2014 |
|
Certification/Extension First Posted : |
February 13, 2014
(Estimate)
|
|
|
Last Update Submitted that Met QC Criteria : |
September 17, 2014 |
|
Last Update Posted : |
September 23, 2014
(Estimate)
|
|
